Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Immunoglobulins Market Size & Share to Surpass USD 27.7 Billion by 2031…
A significant driver is the increasing awareness and acceptance of immunoglobulin therapies among healthcare professionals and patients. As understanding of immunoglobulin treatments improves, more healthcare providers are recommending them for a broader range of conditions, leading to increased demand and market growth. A significant driver is the increasing awareness and acceptance of immunoglobulin therapies among healthcare professionals and patients. As understanding of immunoglobulin...
PR Newswire
16/07/2024
Pharmaceutical Inspection Machines Market Set to Reach USD 1.4 Billion by 2029…
Browse in-depth TOC on "Pharmaceutical Inspection Machines Market" Browse in-depth TOC on "Pharmaceutical Inspection Machines Market" 465 - Tables 51 - Figures 438 - Pages Market Segmentation by Component The market is categorized by component into inspection systems and software. The inspection systems segment includes vision inspection systems, X-ray inspection systems, leak detection systems, metal detectors, combination systems, checkweighers, and other types of...
PR Newswire
16/07/2024
Animal Health Market is Expected to Surpass USD 117.48 Billion Mark by 2031…
Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/animal-health-market Animal Health Market Overview: Segments covered in Animal Health Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/animal-health-market Pharmaceutical Products to Promote Animal Health Estimated to Bring in Major Revenue Pharmaceuticals and drugs play a crucial role...
PR Newswire
16/07/2024
Electric Fireplace Market is to reach USD 2722.61 Mn by 2030 creating…
The Electric Fireplace Market Report offers a comprehensive analysis of the global Electric Fireplace industry, delving into various factors driving its growth, challenges encountered, and emerging trends shaping its trajectory. The report covers a wide range of topics, including market size, important market segments, regional analysis, competitive landscape, and prospects. Through a meticulous research methodology, the report leverages a blend of primary and secondary research techniques…
PR Newswire
16/07/2024
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical…
Breast cancer is a significant global health concern with documented impact in all countries.1 Once diagnosed, patients are faced with difficult decisions regarding available treatment options. Breast conservation therapy (BCT), which includes breast conserving surgery (BCS) plus radiation therapy, may be recommended. However, BCS is associated with a high rate of re-operation with nearly one-in-five patients requiring a follow up procedure within weeks of the initial excision to address…
PR Newswire
16/07/2024
Global Hand Tools Market Grows with Rising Industrial Demand, Finds Maximize…
The Global Hand Tools Market size was valued at USD 24201.21 Million in 2023 and the total global Hand Tools revenue is expected to grow at a CAGR of 4.07% from 2024 to 2030, reaching nearly USD 32006.75 Million by 2030. The Global Hand Tools Market size was valued atUSD 24201.21 Millionin 2023 and the total global Hand Tools revenue is expected to grow at a CAGR of 4.07% from 2024 to 2030, reaching nearlyUSD 32006.75 Millionby 2030. Get your Sample PDF:...
PR Newswire
16/07/2024
Benzodiazepine Drugs Market to Reach US$ 3.2 Billion by 2034, Growing at 3.5%…
With the changing lifestyles and mounting pressures to cope with an accelerated pace of living, many people have been facing psychological issues. The growing prevalence of trauma, anxiety, mental fatigue, and many other psychological conditions is observed to have increased recently. With the changing lifestyles and mounting pressures to cope with an accelerated pace of living, many people have been facing psychological issues. The growing prevalence of trauma, anxiety, mental fatigue, and...
PR Newswire
16/07/2024
Autoimmune Disease Diagnostics Market to be Worth $10.55 Billion by 2031 -…
Various tests such as antinuclear antibodies (ANA), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor, immunoglobulins, and routine blood tests can be done to diagnose and monitor autoimmune diseases. These tests detect systemic autoimmune diseases affecting multiple organs or systems or specific autoimmune diseases. The increasing prevalence of autoimmune disorders, the growing emphasis on early diagnosis, and the rising awareness regarding autoimmune diseases…
PR Newswire
16/07/2024
YourBio Health and RecoveryTrek Partner to Offer Painless and Convenient Alcohol…
"As part of our mission to transform recovery, monitoring and health & wellness and enable participants, as well as consumers to take control of their health and journey through recovery, we are thrilled to partner with YourBio Health to make it easier, more convenient and less painful for people to access critical testing," said Kirk Cizerle, CEO of RecoveryTrek. "By offering TAP® devices for clinical-grade blood sampling as part of our testing kits – available through our…
PR Newswire
16/07/2024
For the First Time in the Middle East In-Utero Endoscopic Surgery at KFSHRC…
RIYADH, Saudi Arabia, July16, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh successfully performed life-changing surgery on a 26-week-old fetus correcting a congenital spinal defect. This pioneering procedure, the first of its kind in the Middle East, was carried out using fetal endoscopic surgery, providing the family with newfound hope and relief. The early intervention not only aims to enhance the baby's future health and...
Nasdaq GlobeNewswire
16/07/2024
Athletes' health - effects of environmental pollutants and nutrition on…
While modern living conditions expose us to a variety of toxic and harmful substances, athletes are faced with particular challenges due to their increased risk of exposure to these substances. Various cleaning products, air pollutants, small plastic particles (micro and nanoplastic) and food additives can damage the barrier function of skin and mucous membranes, which can lead to a disturbed composition of the microbiome (skin and intestinal bacterial flora) and chronic inflammatory reactions…
PR Newswire
16/07/2024
Shaping the Future: Forum 30, The MPHO Safety and Traceability Summit in Rome
Purpose:1. Facilitate a global consensus on advancing MPHO safety and reliability for the patient's benefit.2. Provide a forum to address healthcare informatics standards, terminology, and coding supporting global MPHO biovigilance and traceability. Purpose:1. Facilitate a global consensus on advancing MPHO safety and reliability for the patient's benefit. 2. Provide a forum to address healthcare informatics standards, terminology, and coding supporting global MPHO biovigilance and...
PR Newswire
16/07/2024
Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024
- Aims to accelerate the widespread adoption of syndromic PCR testing to create "a world free from all diseases" - Aims to accelerate the widespread adoption of syndromic PCR testing to create "a world free from all diseases" SEOUL, South Korea,July 16, 2024/PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, demonstrated its human papillomavirus (HPV) diagnostic products and underscored the…
PR Newswire
16/07/2024
Metabolon Expands Library to Include 70 Pesticides, Advancing Human Exposome…
"Employing metabolomics to measure the exposome results in a better understanding of the collective health effects of environmental chemicals, including pesticides," said Ro Hastie, President & CEO at Metabolon. "Our latest library expansion underscores our commitment to advancing metabolomics research and providing our customers with unique insights into the exposome." "Employing metabolomics to measure the exposome results in a better understanding of the…
PR Newswire
16/07/2024
Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™…
Central AI-Immunology™ Building Block:Evaxion's proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platformImproved Performance:Utilizing a state-of-the-art novel deep-learning framework as well as training on public and proprietary data, Evaxion has improved the performance of EvaxMHC compared to publicly available tools Precision in Vaccine Target Prediction:These advancements in EvaxMHC's performance are anticipated to further enhance...
Nasdaq GlobeNewswire
16/07/2024
AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC)…
AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024 Three oral presentations at the Alzheimer's Association International Conference (AAIC 2024), including talks on morADC, ACI-24.060, and ACI-19626 Lausanne, Switzerland, July 16, 2024– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced...
Nasdaq GlobeNewswire
16/07/2024
Uveitis Treatment Market Size is Estimated at $1.4 Billion by 2034, Growing at a…
Advanced treatment methods, which include biodegradable microspheres and intravitreal implants, provide significant advantages since they directly administer prolonged pharmaceutical exposure to the affected eye tissues. Reducing the need for repeated injections or systemic medications lowers the risk of undesirable systemic effects while increasing patient compliance and convenience. Advanced treatment methods, which include biodegradable microspheres and intravitreal implants, provide...
PR Newswire
16/07/2024
Soft N Dry Tree Free Diapers Now in European Markets
European Expansion and Compliance with EUDR European Expansion and Compliance with EUDR The entry of Soft N Dry's Tree Free disposable baby diapers into the European market marks a significant milestone for the company. Retailers inFrance,Germany, and the UK can now offer these eco-friendly products under their own house or private label brands, providing a sustainable alternative to traditional disposable diapers. This move is timely, aligning with the EU's new Deforestation-Free...
PR Newswire
16/07/2024
Esophageal Cancer Market Size to be Worth USD 4.6 billion by 2034, Growing at…
The esophageal cancer market is experiencing significant growth driven by several key factors influencing diagnosis, treatment, and research efforts globally. Esophageal cancer, a malignancy affecting the lining of the esophagus, poses substantial challenges due to its often late-stage diagnosis and aggressive nature. The market's expansion is primarily propelled by an increasing incidence of risk factors such as smoking, heavy alcohol consumption, and gastroesophageal reflux disease (GERD)…
PR Newswire
16/07/2024
Sobi Q2 2024 report: Strong delivery driven by robust portfolio performance
Second Quarter 2024 Second Quarter 2024 Outlook 2024 - updated The strategic portfolio includes Sobi's medicines Aspaveli/Empaveli, Doptelet excludingChina, Gamifant, Vonjo and Zynlonta ®, and royalty on Sanofi's sales on Altuviiio ® and Beyfortus ®. Investors, analysts and media are invited to participate in a conference call, which will include a presentation of the results and a Q&A session on the same day at14:00 CEST. The presentation can be followed livehere...
PR Newswire
16/07/2024
EEG Devices Market is set to grow from US$ 1.7 Bn in 2024 to USD 4.7 Bn by 2034…
With the rising prevalence of neurological disorders, the necessity to employ key diagnostics methods emerges. Due to this, many medical professionals are seen to be inclined toward using efficient as well as accurate methods that can deliver optimum results. With the rising prevalence of neurological disorders, the necessity to employ key diagnostics methods emerges. Due to this, many medical professionals are seen to be inclined toward using efficient as well as accurate methods that can...
PR Newswire
16/07/2024
EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics…
Asceneuron has completed five early-stage clinical trials, showing that their treatment effectively reaches the brain and targets the OGA enzyme. Asceneuron plans to initiate its first Phase 2 clinical study later this year. Asceneuron has completed five early-stage clinical trials, showing that their treatment effectively reaches the brain and targets the OGA enzyme. Asceneuron plans to initiate its first Phase 2 clinical study later this year. Barbara Angehrn Pavik, Chief Executive...
PR Newswire
16/07/2024
Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking…
ASN51's unique mode of action and convenient oral formulation make it an ideal therapy for patients with Alzheimer's disease. Asceneuron has completed five Phase 1 clinical trials, demonstrating complete central nervous system uptake and high OGA enzyme occupancy. Asceneuron plans to initiate its first Phase 2 clinical study later this year. ASN51's unique mode of action and convenient oral formulation make it an ideal therapy for patients with Alzheimer's disease. Asceneuron has completed…
PR Newswire
16/07/2024
Novo Holdings leads $100 million Series C financing of Asceneuron to advance…
ASN51's unique mode of action and convenient oral formulation make it an ideal therapy for patients with Alzheimer's disease. Asceneuron has completed five Phase 1 clinical trials, demonstrating complete central nervous system uptake and high OGA enzyme occupancy, indicating its potential for differentiation from its competitors. Asceneuron plans to initiate its first Phase 2 clinical study later this year. ASN51's unique mode of action and convenient oral formulation make it an ideal therapy...
PR Newswire
16/07/2024
Altri Comunicati